• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植中非遗传母体抗原的耐受性作用。

Tolerogenic effect of non-inherited maternal antigens in hematopoietic stem cell transplantation.

机构信息

Department of Pediatrics and Cell Transplantation, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

出版信息

Front Immunol. 2012 May 25;3:135. doi: 10.3389/fimmu.2012.00135. eCollection 2012.

DOI:10.3389/fimmu.2012.00135
PMID:22654885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3360462/
Abstract

Major histocompatibility complex antigens that provoke severe transplant reactions are referred to as the human leukocyte antigen (HLA) in human and as the H-2 in mice. Even if the donor and recipient are HLA-identical siblings, graft-versus-host reactions have been linked to differences in the minor histocompatibility antigen. As the chance of finding an HLA-identical sibling donor is only 25%, attention has been focused on using alternative donors. An HLA-mismatched donor with non-inherited maternal antigens (NIMA) is less immunogenic than that with non-inherited paternal antigens, because the contact between the immune systems of the mother and child during pregnancy affects the immune response of the child against NIMA. However, the immunologic effects of developmental exposure to NIMA are heterogeneous, and can be either tolerogenic or immunogenic. We recently have devised a novel method for predicting the tolerogenic effect of NIMA. In this review, we overview the evidence for the existence of the NIMA tolerogenic effect, the possible cellular and molecular basis of the phenomenon, and its utilization in hematopoietic stem cell transplantation. We suggest a future direction for the safe clinical use of this phenomenon, fetomaternal tolerance, in the transplantation field.

摘要

主要组织相容性复合体抗原引发严重的移植反应,在人类中被称为人类白细胞抗原(HLA),在小鼠中被称为 H-2。即使供体和受体是 HLA 完全匹配的兄弟姐妹,移植物抗宿主反应也与次要组织相容性抗原的差异有关。由于找到 HLA 完全匹配的兄弟姐妹供体的机会只有 25%,因此人们一直关注使用替代供体。与非遗传父系抗原(NIMA)相比,具有 HLA 不匹配的供体的免疫原性较低,因为妊娠期间母亲和孩子的免疫系统之间的接触会影响孩子对 NIMA 的免疫反应。然而,对 NIMA 的发育性暴露的免疫效应是异质的,既可以是耐受原性的,也可以是免疫原性的。我们最近设计了一种预测 NIMA 耐受原性效应的新方法。在这篇综述中,我们概述了 NIMA 耐受原性效应的存在证据、该现象的可能细胞和分子基础,以及其在造血干细胞移植中的应用。我们建议在移植领域中为这种现象(胎母耐受)的安全临床应用开辟未来的方向。

相似文献

1
Tolerogenic effect of non-inherited maternal antigens in hematopoietic stem cell transplantation.造血干细胞移植中非遗传母体抗原的耐受性作用。
Front Immunol. 2012 May 25;3:135. doi: 10.3389/fimmu.2012.00135. eCollection 2012.
2
A feasibility study on the prediction of acute graft-vs.-host disease before hematopoietic stem cell transplantation based on fetomaternal tolerance.基于母胎耐受对造血干细胞移植前急性移植物抗宿主病进行预测的可行性研究。
Chimerism. 2013 Jul-Sep;4(3):84-6. doi: 10.4161/chim.24718. Epub 2013 Sep 12.
3
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.对非遗传母体抗原的耐受性对来自父母或 HLA 单倍型相同同胞的骨髓移植后移植物抗宿主病发生情况的影响。
Blood. 2002 Mar 1;99(5):1572-7. doi: 10.1182/blood.v99.5.1572.
4
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism.非遗传母体抗原(NIMA)不匹配的家庭成员间HLA单倍型相合造血干细胞移植与长期胎儿-母体微嵌合体的相关性及可行性
Blood. 2004 Dec 1;104(12):3821-8. doi: 10.1182/blood-2004-03-1212. Epub 2004 Jul 27.
5
Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.非遗传母体抗原互补性HLA不匹配同胞间干细胞移植中的移植物排斥和超急性移植物抗宿主病
Eur J Haematol. 2007 Feb;78(2):157-60. doi: 10.1111/j.1600-0609.2006.00797.x.
6
Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.针对NIMA的主要和次要组织相容性抗原:耐受性NIMA效应的预测
Chimerism. 2011 Jan;2(1):23-4. doi: 10.4161/chim.2.1.15127.
7
Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+ CD25+ T-cell-dependent mechanism.胎儿对母体抗原的耐受性通过依赖CD4 + CD25 + T细胞的机制改善了同种异体骨髓移植的结果。
Blood. 2006 Jan 1;107(1):404-9. doi: 10.1182/blood-2005-07-3045. Epub 2005 Sep 8.
8
Prediction of reactivity to noninherited maternal antigen in MHC-mismatched, minor histocompatibility antigen-matched stem cell transplantation in a mouse model.在 MHC 不合、次要组织相容性抗原匹配的干细胞移植的小鼠模型中预测对非遗传性母源性抗原的反应性。
J Immunol. 2010 Dec 15;185(12):7739-45. doi: 10.4049/jimmunol.1001226. Epub 2010 Nov 15.
9
Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.多中心分析表明,在 HLA 匹配的相关和无关造血干细胞移植后,次要组织相容性抗原对移植物抗宿主病和移植物抗肿瘤效应具有显著的临床影响。
Biol Blood Marrow Transplant. 2013 Aug;19(8):1244-53. doi: 10.1016/j.bbmt.2013.06.001. Epub 2013 Jun 10.
10
Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation.胎儿-母体耐受性在造血干细胞移植中的影响。
Arch Immunol Ther Exp (Warsz). 2006 May-Jun;54(3):165-72. doi: 10.1007/s00005-006-0018-y. Epub 2006 May 2.

引用本文的文献

1
Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies.非匹配亲缘与非匹配无关亲缘单倍体造血干细胞移植治疗血液系统恶性肿瘤的临床结局比较。
Bone Marrow Transplant. 2021 Nov;56(11):2723-2731. doi: 10.1038/s41409-021-01382-y. Epub 2021 Jul 8.
2
Immunological Consequences of Exposure to Foreign Antigens.接触外来抗原的免疫后果。
Front Immunol. 2021 Apr 15;12:638435. doi: 10.3389/fimmu.2021.638435. eCollection 2021.
3
Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD.

本文引用的文献

1
Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.针对NIMA的主要和次要组织相容性抗原:耐受性NIMA效应的预测
Chimerism. 2011 Jan;2(1):23-4. doi: 10.4161/chim.2.1.15127.
2
Minor histocompatibility antigens in Tunisians: could platelet endothelial cell adhesion molecule 1 marker be one of them?突尼斯人的次要组织相容性抗原:血小板内皮细胞黏附分子1标记物会是其中之一吗?
Tissue Antigens. 2011 Jan;77(1):68-73. doi: 10.1111/j.1399-0039.2010.01574.x.
3
Prediction of reactivity to noninherited maternal antigen in MHC-mismatched, minor histocompatibility antigen-matched stem cell transplantation in a mouse model.
髓样分化因子88(MyD88)缺陷的供体骨髓细胞树突状细胞分化偏向,而非作为髓源性抑制细胞大量扩增,会加重移植物抗宿主病(GVHD)。
Immune Netw. 2018 Nov 5;18(6):e44. doi: 10.4110/in.2018.18.e44. eCollection 2018 Dec.
4
Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.胎儿暴露于母体人类血小板抗原-1a不会诱导耐受性。一项分析性观察研究。
PLoS One. 2017 Aug 24;12(8):e0182957. doi: 10.1371/journal.pone.0182957. eCollection 2017.
5
Antigen-specific CD8 T cell feedback activates NLRP3 inflammasome in antigen-presenting cells through perforin.抗原特异性 CD8 T 细胞反馈通过穿孔素激活抗原呈递细胞中的 NLRP3 炎性体。
Nat Commun. 2017 May 24;8:15402. doi: 10.1038/ncomms15402.
6
Dichotomy between T Cell and B Cell Tolerance to Neonatal Retroviral Infection Permits T Cell Therapy.T细胞和B细胞对新生儿逆转录病毒感染的耐受性差异使得T细胞疗法成为可能。
J Immunol. 2016 Nov 1;197(9):3628-3638. doi: 10.4049/jimmunol.1600734. Epub 2016 Sep 19.
7
Tolerance to noninherited maternal antigens, reproductive microchimerism and regulatory T cell memory: 60 years after 'Evidence for actively acquired tolerance to Rh antigens'.对非遗传母体抗原的耐受性、生殖微嵌合体与调节性T细胞记忆:自“Rh抗原主动获得性耐受的证据”发表60年后
Chimerism. 2015 Apr 3;6(1-2):8-20. doi: 10.1080/19381956.2015.1107253. Epub 2015 Oct 30.
8
Cross-Generational Reproductive Fitness Enforced by Microchimeric Maternal Cells.微嵌合母体细胞对跨代生殖适应性的影响
Cell. 2015 Jul 30;162(3):505-15. doi: 10.1016/j.cell.2015.07.006. Epub 2015 Jul 23.
9
Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.自然获得性微嵌合体:对移植结果的影响及检测新方法
Chimerism. 2014;5(2):24-39. doi: 10.4161/chim.28908.
10
A feasibility study on the prediction of acute graft-vs.-host disease before hematopoietic stem cell transplantation based on fetomaternal tolerance.基于母胎耐受对造血干细胞移植前急性移植物抗宿主病进行预测的可行性研究。
Chimerism. 2013 Jul-Sep;4(3):84-6. doi: 10.4161/chim.24718. Epub 2013 Sep 12.
在 MHC 不合、次要组织相容性抗原匹配的干细胞移植的小鼠模型中预测对非遗传性母源性抗原的反应性。
J Immunol. 2010 Dec 15;185(12):7739-45. doi: 10.4049/jimmunol.1001226. Epub 2010 Nov 15.
4
High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning.高通量全基因组关联扫描分析 10 个新的次要组织相容性抗原。
Cancer Res. 2010 Nov 15;70(22):9073-83. doi: 10.1158/0008-5472.CAN-10-1832. Epub 2010 Nov 9.
5
The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation.人类“Treg混合淋巴细胞反应”:对FOXP3 +调节性T细胞生成的免疫监测
Transplantation. 2009 Dec 15;88(11):1303-11. doi: 10.1097/TP.0b013e3181bbee98.
6
Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members.健康家庭成员对次要组织相容性抗原的自然获得性耐受和致敏
Blood. 2009 Sep 10;114(11):2263-72. doi: 10.1182/blood-2009-01-200410. Epub 2009 Jun 8.
7
Long-term survival after HLA-haploidentical SCT from noninherited maternal antigen-mismatched family donors: impact of chronic GVHD.来自非遗传母源抗原不匹配家庭供者的人类白细胞抗原单倍型相合造血干细胞移植后的长期生存:慢性移植物抗宿主病的影响
Bone Marrow Transplant. 2009 Sep;44(5):327-9. doi: 10.1038/bmt.2009.18. Epub 2009 Feb 16.
8
Improved outcome of allogeneic bone marrow transplantation due to breastfeeding-induced tolerance to maternal antigens.母乳喂养诱导对母体抗原的耐受性可改善异基因骨髓移植的预后。
Blood. 2009 Feb 19;113(8):1829-33. doi: 10.1182/blood-2008-05-155283. Epub 2009 Jan 5.
9
Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.母体同种异体抗原促进子宫内耐受性胎儿调节性T细胞的发育。
Science. 2008 Dec 5;322(5907):1562-5. doi: 10.1126/science.1164511.
10
Tolerance induction or sensitization in mice exposed to noninherited maternal antigens (NIMA).暴露于非遗传母体抗原(NIMA)的小鼠中的耐受性诱导或致敏作用。
Am J Transplant. 2008 Nov;8(11):2307-15. doi: 10.1111/j.1600-6143.2008.02417.x.